• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Quality control programme for the preparation of small-pool lyophilized heat-treated cryoprecipitates.

作者信息

Allersma D P, Swüste F, Briët E, Van der Does J A

机构信息

Central Pharmacy of the Hospitals of The Hague, The Netherlands.

出版信息

Pharm Weekbl Sci. 1991 Feb 22;13(1):24-31. doi: 10.1007/BF01963880.

DOI:10.1007/BF01963880
PMID:1903527
Abstract

International and national documents on and standards for quality control have been introduced for Blood Banks. Recently, the Standard Registration Document and a National Health Authority Licence for factor VIII preparations based on the Document were introduced in the Netherlands. In the course of developing a preparation of lyophilized heat-treated cryoprecipitates in our Blood Bank, we used this Standard Registration Document and the good pharmaceutical manufacturing practices to design a quality control protocol. The aim of this protocol was to provide documented evidence on the quality of both our product and the production process. The protocol included the validation or revalidation of individual installations and procedures used during production, validation of the whole process and quality control of routine production. With our quality protocol we have been able to demonstrate that our preparation is consistently of the intended quality.

摘要

相似文献

1
Quality control programme for the preparation of small-pool lyophilized heat-treated cryoprecipitates.
Pharm Weekbl Sci. 1991 Feb 22;13(1):24-31. doi: 10.1007/BF01963880.
2
Preparation of lyophilized heat-treated cryoprecipitates from a small pool of plasma obtained by apheresis.通过单采获得的少量血浆制备冻干热处理冷沉淀。
Pharm Weekbl Sci. 1991 Feb 22;13(1):18-23. doi: 10.1007/BF01963879.
3
Development and small-scale production of a severely heated factor VIII concentrate.一种经过深度加热的凝血因子VIII浓缩物的研发与小规模生产。
Vox Sang. 1994;66(2):89-95. doi: 10.1111/j.1423-0410.1994.tb00288.x.
4
Storage of whole blood for up to 24 hours at ambient temperature before component preparation: implementation in the Netherlands.全血在组件制备前于室温下储存长达 24 小时:在荷兰的实施情况。
Transfusion. 2011 Jan;51 Suppl 1:3S-6S. doi: 10.1111/j.1537-2995.2010.02957.x.
5
Development of a heat-treated factor VIII/von Willebrand factor concentrate prepared from heparinized plasma.由肝素化血浆制备的热处理凝血因子VIII/血管性血友病因子浓缩物的研发。
Thromb Haemost. 1990 Jun 28;63(3):392-402.
6
Influence of heat treatment on FVIII:C recovery from freeze dried cryoprecipitate.热处理对冻干冷沉淀中FVIII:C回收率的影响。
J Clin Pathol. 1988 Sep;41(9):945-7. doi: 10.1136/jcp.41.9.945.
7
What is the importance of the 'small pool concept' in the preparation of fraciton I and cryoprecipitates for the prevention of post-transfusion hepatitis?“小池概念”在制备I因子和冷沉淀以预防输血后肝炎方面有何重要性?
Vox Sang. 1980 Feb;38(2):106-19.
8
Plasma and cryoprecipitate manufactured from whole blood held overnight at room temperature meet quality standards.在室温下放置过夜的全血制备的血浆和冷沉淀符合质量标准。
Transfusion. 2010 Feb;50(2):344-53. doi: 10.1111/j.1537-2995.2009.02441.x. Epub 2009 Oct 15.
9
[Factor VIII:C activity during heat inactivation of viruses in cryoprecipitates].[冷沉淀中病毒热灭活过程中的凝血因子 VIII:C 活性]
Lijec Vjesn. 1990 Jul-Aug;112(7-8):212-5.
10
Heat inactivation of human immunodeficiency virus in lyophilized factor VIII and factor IX concentrates.冻干的凝血因子 VIII 和凝血因子 IX 浓缩物中人类免疫缺陷病毒的热灭活
Thromb Res. 1987 Jul 15;47(2):235-41. doi: 10.1016/0049-3848(87)90380-x.

引用本文的文献

1
Preparation of lyophilized heat-treated cryoprecipitates from a small pool of plasma obtained by apheresis.通过单采获得的少量血浆制备冻干热处理冷沉淀。
Pharm Weekbl Sci. 1991 Feb 22;13(1):18-23. doi: 10.1007/BF01963879.

本文引用的文献

1
Determination of serum proteins by means of the biuret reaction.通过双缩脲反应测定血清蛋白。
J Biol Chem. 1949 Feb;177(2):751-66.
2
[Rapid physiological coagulation method in determination of fibrinogen].[快速生理凝血法测定纤维蛋白原]
Acta Haematol. 1957 Apr;17(4):237-46. doi: 10.1159/000205234.
3
What are the critical factors in the production and quality control of frozen plasma intended for direct transfusion or for fractionation to provide medically needed labile coagulation factors?对于用于直接输血或用于分馏以提供医学所需的不稳定凝血因子的冷冻血浆,其生产和质量控制中的关键因素有哪些?
Vox Sang. 1983;44(4):246-59.
4
In vitro and in vivo characterization of factor VIII preparations.
Vox Sang. 1980 Feb;38(2):68-80. doi: 10.1111/j.1423-0410.1980.tb02333.x.
5
A calculator program for individualizing factor VIII dosage.用于个体化凝血因子VIII剂量的计算器程序。
Drug Intell Clin Pharm. 1984 Sep;18(9):726-30. doi: 10.1177/106002808401800911.
6
Clinical pharmacokinetics of factor VIII in patients with classic haemophilia.
Clin Pharmacokinet. 1987 Dec;13(6):365-80. doi: 10.2165/00003088-198713060-00002.
7
Freezing of plasma and recovery of factor VIII.
Transfusion. 1986 Mar-Apr;26(2):159-62. doi: 10.1046/j.1537-2995.1986.26286152906.x.
8
Preparation of lyophilized heat-treated cryoprecipitates from a small pool of plasma obtained by apheresis.通过单采获得的少量血浆制备冻干热处理冷沉淀。
Pharm Weekbl Sci. 1991 Feb 22;13(1):18-23. doi: 10.1007/BF01963879.
9
Contribution to the optimal use of human blood. VII. Increase of the yield of factor VIII in four-donor cryoprecipitate by an improved processing of blood and plasma.对人类血液合理利用的贡献。VII. 通过改进血液和血浆处理方法提高四供体冷沉淀中凝血因子VIII的产量
Vox Sang. 1976;30(1):1-22. doi: 10.1111/j.1423-0410.1976.tb04830.x.
10
The effects of temperature variations on cryoprecipitate.温度变化对冷沉淀的影响。
Transfusion. 1979 Jan-Feb;19(1):86-9. doi: 10.1046/j.1537-2995.1979.19179160274.x.